Your browser doesn't support javascript.
loading
The Discovery of Naringenin as Endolysosomal Two-Pore Channel Inhibitor and Its Emerging Role in SARS-CoV-2 Infection.
D'Amore, Antonella; Gradogna, Antonella; Palombi, Fioretta; Minicozzi, Velia; Ceccarelli, Matteo; Carpaneto, Armando; Filippini, Antonio.
Affiliation
  • D'Amore A; Unit of Histology and Medical Embryology, Department of Anatomy, Histology, Forensic Medicine and Orthopaedics, Sapienza University of Rome, 16 Via A. Scarpa, 00161 Rome, Italy.
  • Gradogna A; Institute of Biophysics, National Research Council, Via De Marini 6, 16149 Genova, Italy.
  • Palombi F; Unit of Histology and Medical Embryology, Department of Anatomy, Histology, Forensic Medicine and Orthopaedics, Sapienza University of Rome, 16 Via A. Scarpa, 00161 Rome, Italy.
  • Minicozzi V; INFN and Department of Physics, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133 Roma, Italy.
  • Ceccarelli M; Department of Physics, University of Cagliari, 09042 Monserrato, Italy.
  • Carpaneto A; IOM-CNR Unità di Cagliari, Cittadella Universitaria, 09042 Monserrato, Italy.
  • Filippini A; Institute of Biophysics, National Research Council, Via De Marini 6, 16149 Genova, Italy.
Cells ; 10(5)2021 05 07.
Article de En | MEDLINE | ID: mdl-34067054
ABSTRACT
The flavonoid naringenin (Nar), present in citrus fruits and tomatoes, has been identified as a blocker of an emerging class of human intracellular channels, namely the two-pore channel (TPC) family, whose role has been established in several diseases. Indeed, Nar was shown to be effective against neoangiogenesis, a process essential for solid tumor progression, by specifically impairing TPC activity. The goal of the present review is to illustrate the rationale that links TPC channels to the mechanism of coronavirus infection, and how their inhibition by Nar could be an efficient pharmacological strategy to fight the current pandemic plague COVID-19.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Inhibiteurs des canaux calciques / Canaux calciques / Flavanones / Traitements médicamenteux de la COVID-19 / Tumeurs Limites: Humans Langue: En Journal: Cells Année: 2021 Type de document: Article Pays d'affiliation: Italie

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Inhibiteurs des canaux calciques / Canaux calciques / Flavanones / Traitements médicamenteux de la COVID-19 / Tumeurs Limites: Humans Langue: En Journal: Cells Année: 2021 Type de document: Article Pays d'affiliation: Italie
...